Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Statement on Senate Confirmation of Dr. Robert Califf as FDA Commissioner
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement upon the U.S. Senate’s vote to confirm Dr. Robert Califf as FDA Commissioner.
HDA Recommends a Phased Approach to Implementing the Final Requirements of the DSCSA
The Healthcare Distribution Alliance (HDA) is recommending to the Food and Drug Administration (FDA) a phased approach to final implementation of the Drug Supply Chain Security Act (DSCSA) to minimize the potential for supply disruptions and interruptions to patient care. The proposal was communicated through a recent letter to FDA.
Chip Davis Shares HDA’s 2024 Policy Priorities in Annual Chain Drug Review Column
With a presidential election on the horizon and policymakers working to develop solutions to challenges facing patients and providers, HDA’s President and CEO Chip Davis provided key insights into the association’s 2024 policy priorities in his annual column, “Health Care Outlook,” by Chain Drug Review.